Atlas Trials

Multimodal Investigation of the Neuroprotective Effects of Resveratrol (MINER)

Clinical trial NCT03665740 · UNKNOWN

Trial details

NCT number
NCT03665740
Sponsor
VISN 17 Center of Excellence
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Gulf War Illness
Start date
2018-08-01
Primary completion
2022-08-31
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.